Dr. Lovell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3333 Burnet Ave
Ml 4010
Cincinnati, OH 45229Phone+1 513-636-7686Fax+1 513-636-5568- Is this information wrong?
Education & Training
- Baylor College of MedicineFellowship, Rheumatology, 1982 - 1984
- University of Texas School of Public HealthM.P.H., Biostatistics/Study Design, 1982 - 1984
- Children’s Mercy HospitalResidency, Pediatrics, 1978 - 1981
- University of Kansas School of MedicineClass of 1978
- University of KansasB.A., Philosophy, 1969 - 1975
Certifications & Licensure
- IN State Medical License 2024 - 2025
- KY State Medical License 2021 - 2025
- OH State Medical License 1984 - 2024
- FL State Medical License 2015 - 2017
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Rheumatology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Innovative Educator Award American College of Rheumatology, 2007
- Distinguished Clinical Investigator American College of Rheumatology, 2007
- Join now to see all
Clinical Trials
- Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis Start of enrollment: 1996 Jun 01
- Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis Start of enrollment: 2002 Aug 01
- Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA Start of enrollment: 2009 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry.Lovell, D., Tzaribachev, N., Henrickson, M., Simonini, G., Griffin, T., Alexeeva, E., Bohnsack, J., Zeft, A., Horneff, G., Vehe, R., Staņēviča, V., Tarvin, S., Trachan...> ;Rheumatology. 2024 Jan 18
- The 4th NextGen Therapies for SJIA and MAS: part 1 the elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-on...de Benedetti, F., Vastert, S., Nigrovic, P., Kimura, Y., Lovell, D.> ;Pediatric Rheumatology Online Journal. 2024 Jan 5
- Panuveitis and optic neuropathy following SARS-COV-2 in the absence of multisystem inflammatory syndrome in a child.Preston Land, Veeral Shah, Daniel J Lovell, Virginia Miraldi Utz> ;American Journal of Ophthalmology Case Reports. 2023 Dec 1
- Join now to see all
Journal Articles
- Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016Hermine I Brunner, Melissa L Mannion, Judyann C Olson, Vibeke Strand, Daniel J Lovell, Meredith P Riebschleger, Susan Shenoi, Journal of Rheumatology
- Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trialOddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC, Barohn RJ, Feldman BM, Harris-Love MO, Koontz DC, Fertig N, Kelley SS, Pryber SL, Miller FW, Rocket..., Arthritis Rheum, 2/1/2013
- American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritisWallace CA, Giannini EH, Huang B, Itert L, Ruperto N; Childhood Arthritis Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Paediatric ..., Arthritis Care Res, 7/1/2011
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Efficacy and safety of abatacept in children and adolescents with active juvenile idiopathic arthritis (JIA): Results of double-blind withdrawal phaseBlock AJ, Ruperto N, Lovell DJ, Giannini EH, Martini A, Rheumatology, 1/1/2007
- The long-term safety of etanercept in children with polyarticular or systemic juvenile rheumatoid arthritisGiannini EH, Ilowite NT, Lovell DJ, et al, Annals of Rheumatic Diseases, 1/1/2007
- Safety of over 8 years of continuous etanercept therapy in patients with juvenile rheumatoid arthritisLovell DJ, Giannini EH, Wallace CA et al, Annals of Rheumatic Diseases, 1/1/2007
- Join now to see all
Press Mentions
- Changing Treatment Patterns for Patients with JIAOctober 18th, 2022
- Updated Pediatric Uveitis Recommendations Advise on Expanded Treatment OptionsJune 16th, 2022
- Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic DiseasesNovember 3rd, 2021
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: